Quantessence Capital’s Albemarle ALB Stock Holding History

Quantessence Capital’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,781	Closed	-$989K	–	180
2025 Q2	$989K	Buy	+15,781	New	+$933K	0.29%	82

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quantessence Capital's ALB Position: Q3 2025 in Review

Quantessence Capital sold out of Albemarle (ALB) in Q3 2025, closing a stake of 15,781 shares — an estimated $989K sold.

Quantessence Capital first reported a position in ALB in Q2 2025 and held it in 1 quarter. The position peaked at $989K in Q2 2025. 767 funds tracked by Wall St. Rank hold ALB as of Q3 2025.

Quantessence Capital reported no remaining Albemarle position as of Q3 2025 after selling out during the quarter.
Quantessence Capital sold 15,781 Albemarle shares in Q3 2025, an estimated $989K.
Quantessence Capital first reported a position in Albemarle in Q2 2025 and held it in 1 quarter.
Quantessence Capital's Albemarle position peaked at $989K in Q2 2025.
767 funds tracked by Wall St. Rank held Albemarle as of Q3 2025.

Based on Quantessence Capital's 13F filing for Q3 2025, filed 14 Nov 2025.